{"id":387779,"date":"2020-11-24T09:38:24","date_gmt":"2020-11-24T14:38:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387779"},"modified":"2020-11-24T09:38:24","modified_gmt":"2020-11-24T14:38:24","slug":"scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/","title":{"rendered":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences"},"content":{"rendered":"
\n

JERSEY CITY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX<\/a>), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the Company\u2019s participation in Piper Sandler\u2019s 32nd<\/sup> Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI\u2019s 3rd<\/sup> Annual HealthCONx Conference taking place on December 2, 2020.<\/p>\n

\n Presentation details<\/strong>
\n :<\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n Piper Sandler 32<\/strong>
\n
\n nd<\/strong>
\n <\/sup>
\n Annual Virtual Healthcare Conference:<\/strong>\n <\/td>\n<\/tr>\n
Presentation Date:<\/td>\nMonday, November 23 to Thursday, December 3, 2020<\/td>\n<\/tr>\n
Presentation Time:<\/td>\n8:00 a.m. \u2013 5:00 p.m. ET<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Link<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
\n Evercore ISI 3<\/strong>
\n
\n rd<\/strong>
\n <\/sup>
\n Annual HealthCONx Conference<\/strong>
\n :<\/strong>\n <\/td>\n<\/tr>\n
Panel Discussion Topic:<\/td>\nNo Fungus Among Us: Addressing an Important Need with Cidara, F2G, and SCYNEXIS<\/td>\n<\/tr>\n
Presentation Date:<\/td>\nWednesday, December 2, 2020<\/td>\n<\/tr>\n
Presentation Time:<\/td>\n11:20 a.m. \u2013 12:05 p.m. ET<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n<\/table>\n

A webcast of both presentation recordings will be available for 30 days and can be found on the Scynexis website at: https:\/\/www.scynexis.com\/news-media\/events<\/a>.<\/p>\n

\n About\u00a0SCYNEXIS<\/strong>
\n
SCYNEXIS, Inc.\u00a0(NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to potentially help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. Our lead candidate,\u00a0ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV\/oral antifungal agent representing a novel therapeutic class, in late stage development for multiple indications, ranging from vaginal yeast infections to life-threatening fungal infections in hospitalized patients. The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization. For more information, visit\u00a0www.scynexis.com<\/a>.<\/p>\n

\n
\n CONTACT<\/u>
\n <\/strong>
\n :\u00a0<\/strong>
\n
\n Investor Relations<\/strong>
\n
Irina Koffler
LifeSci Advisors
Tel: (646) 970-4681
ikoffler@lifesciadvisors.com<\/a><\/p>\n

\n Media Relations<\/strong>
\n
Gloria Gasaatura
LifeSci Communications
Tel: (646) 970-4688
ggasaatura@lifescicomms.com<\/a><\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

JERSEY CITY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the Company\u2019s participation in Piper Sandler\u2019s 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI\u2019s 3rd Annual HealthCONx Conference taking place on December 2, 2020. Presentation details : Piper Sandler 32 nd Annual Virtual Healthcare Conference: Presentation Date: Monday, November 23 to Thursday, December 3, 2020 Presentation Time: 8:00 a.m. \u2013 5:00 p.m. ET Webcast: Link \u00a0 Evercore ISI 3 rd Annual HealthCONx … <\/p>\n

Continue reading “SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387779","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JERSEY CITY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the Company\u2019s participation in Piper Sandler\u2019s 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI\u2019s 3rd Annual HealthCONx Conference taking place on December 2, 2020. Presentation details : Piper Sandler 32 nd Annual Virtual Healthcare Conference: Presentation Date: Monday, November 23 to Thursday, December 3, 2020 Presentation Time: 8:00 a.m. \u2013 5:00 p.m. ET Webcast: Link \u00a0 Evercore ISI 3 rd Annual HealthCONx … Continue reading "SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T14:38:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences\",\"datePublished\":\"2020-11-24T14:38:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/\",\"name\":\"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==\",\"datePublished\":\"2020-11-24T14:38:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/","og_locale":"en_US","og_type":"article","og_title":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk","og_description":"JERSEY CITY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the Company\u2019s participation in Piper Sandler\u2019s 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI\u2019s 3rd Annual HealthCONx Conference taking place on December 2, 2020. Presentation details : Piper Sandler 32 nd Annual Virtual Healthcare Conference: Presentation Date: Monday, November 23 to Thursday, December 3, 2020 Presentation Time: 8:00 a.m. \u2013 5:00 p.m. ET Webcast: Link \u00a0 Evercore ISI 3 rd Annual HealthCONx … Continue reading \"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T14:38:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences","datePublished":"2020-11-24T14:38:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/","name":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==","datePublished":"2020-11-24T14:38:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTU5OCMzODQyMjUzIzUwMDA3MDcxOA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-piper-sandler-and-evercore-isi-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387779"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387779\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}